Name | Bromoacetamido-PEG2- NHS ester |
---|---|
Synonyms |
Acetamide, 2-bromo-N-[2-[2-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropoxy]ethoxy]ethyl]-
2-Bromo-N-[2-(2-{3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropoxy}ethoxy)ethyl]acetamide MFCD20926375 |
Description | Bromoacetamido-PEG2-C2-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
---|---|
Related Catalog | |
Target |
PEGs Alkyl/ether |
In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C13H19BrN2O7 |
Molecular Weight | 395.203 |
Exact Mass | 394.037567 |
LogP | -2.11 |
Index of Refraction | 1.540 |